• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核分枝杆菌中异烟肼耐药的机制:对在异烟肼耐药临床分离株中鉴定出的烯酰还原酶突变体的酶学特性分析

Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates.

作者信息

Basso L A, Zheng R, Musser J M, Jacobs W R, Blanchard J S

机构信息

Department of Biochemistry and Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

出版信息

J Infect Dis. 1998 Sep;178(3):769-75. doi: 10.1086/515362.

DOI:10.1086/515362
PMID:9728546
Abstract

Mutants in the structural gene of the inhA-encoded NADH-dependent 2-trans enoyl-acyl carrier protein reductase were identified from isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Recombinant InhA proteins with defined single amino acid replacements were expressed in Escherichia coli and purified to homogeneity. Steady-state kinetic parameters for wild type (WT) and I16T, I21V, I47T, and I95P mutants of the enoyl reductase were measured spectrophotometrically. NADH binding to WT and I16T, I21V, I47T, S94A, and I95P mutant reductases were determined by fluorescence spectroscopy and demonstrated that all mutant enzymes had reduced NADH affinity and that NADH binding to all mutants was cooperative as compared with the hyperbolic binding of NADH to the WT enzyme. Since KatG-produced electrophilic derivatives of isoniazid have been suggested to inactivate the enoyl reductase-NADH complex, the kinetics of inactivation for the WT and I21V and I95P mutants was determined. Both mutations resulted in significantly increased values for the apparent first-order rate constant of inactivation.

摘要

从结核分枝杆菌的异烟肼耐药临床分离株中鉴定出inhA编码的NADH依赖性2-反式烯酰-酰基载体蛋白还原酶结构基因中的突变体。在大肠杆菌中表达具有确定的单氨基酸替换的重组InhA蛋白,并纯化至同质。通过分光光度法测量烯酰还原酶野生型(WT)以及I16T、I21V、I47T和I95P突变体的稳态动力学参数。通过荧光光谱法测定NADH与WT以及I16T、I21V、I47T、S94A和I95P突变体还原酶的结合,结果表明所有突变酶对NADH的亲和力均降低,并且与NADH与WT酶的双曲线结合相比,NADH与所有突变体的结合具有协同性。由于已表明KatG产生的异烟肼亲电衍生物可使烯酰还原酶-NADH复合物失活,因此测定了WT以及I21V和I95P突变体的失活动力学。这两种突变均导致失活的表观一级速率常数显著增加。

相似文献

1
Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates.结核分枝杆菌中异烟肼耐药的机制:对在异烟肼耐药临床分离株中鉴定出的烯酰还原酶突变体的酶学特性分析
J Infect Dis. 1998 Sep;178(3):769-75. doi: 10.1086/515362.
2
Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.关于烟酰胺腺嘌呤二核苷酸(NADH)与结核分枝杆菌野生型及异烟肼抗性烯酰-酰基载体蛋白(CoA)还原酶结合的晶体学和稳态前动力学研究。
J Mol Biol. 2006 Jun 9;359(3):646-66. doi: 10.1016/j.jmb.2006.03.055. Epub 2006 Apr 21.
3
Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid.三氯生和异烟肼对结核分枝杆菌烯酰还原酶InhA的抑制作用。
Biochemistry. 2000 Jul 4;39(26):7645-50. doi: 10.1021/bi0008940.
4
Molecular Dynamics Assisted Mechanistic Study of Isoniazid-Resistance against Mycobacterium tuberculosis InhA.分子动力学辅助的异烟肼对结核分枝杆菌InhA耐药性的机制研究
PLoS One. 2015 Dec 14;10(12):e0144635. doi: 10.1371/journal.pone.0144635. eCollection 2015.
5
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance.异烟肼-NAD加合物是结核分枝杆菌烯酰还原酶InhA的一种缓慢、紧密结合的抑制剂:加合物亲和力与耐药性。
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13881-6. doi: 10.1073/pnas.2235848100. Epub 2003 Nov 17.
6
Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.关于异烟酰 - NAD加合物与结核分枝杆菌野生型及异烟肼耐药的2 - 反式烯酰 - ACP(辅酶A)还原酶结合的晶体学研究。
J Struct Biol. 2007 Sep;159(3):369-80. doi: 10.1016/j.jsb.2007.04.009. Epub 2007 May 3.
7
Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex.一种无机配合物对结核分枝杆菌2-反式烯酰-ACP(辅酶A)还原酶的缓慢抑制作用
Curr Pharm Des. 2006;12(19):2409-24. doi: 10.2174/138161206777698927.
8
Molecular dynamics simulation studies of the wild-type, I21V, and I16T mutants of isoniazid-resistant Mycobacterium tuberculosis enoyl reductase (InhA) in complex with NADH: toward the understanding of NADH-InhA different affinities.耐异烟肼结核分枝杆菌烯酰还原酶(InhA)野生型、I21V和I16T突变体与NADH复合物的分子动力学模拟研究:旨在理解NADH与InhA的不同亲和力
Biophys J. 2005 Aug;89(2):876-84. doi: 10.1529/biophysj.104.053512. Epub 2005 May 20.
9
Probing mechanisms of resistance to the tuberculosis drug isoniazid: Conformational changes caused by inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis.探究对结核病药物异烟肼的耐药机制:由结核分枝杆菌烯酰还原酶InhA受抑制引起的构象变化
Protein Sci. 2007 Aug;16(8):1617-27. doi: 10.1110/ps.062749007. Epub 2007 Jun 28.
10
An inorganic iron complex that inhibits wild-type and an isoniazid-resistant mutant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.一种无机铁络合物,可抑制来自结核分枝杆菌的野生型和异烟肼耐药突变体2-反式烯酰基-ACP(CoA)还原酶。
Chem Commun (Camb). 2004 Feb 7(3):312-3. doi: 10.1039/b313592f. Epub 2004 Jan 7.

引用本文的文献

1
Evaluating the Impact of the Tyr158 p on the Mechanism and Inhibition of InhA, the Enoyl-ACP Reductase from .评估 Tyr158p 对 InhA(烯酰基辅酶 A 还原酶)的机制和抑制的影响,InhA 来自 。
Biochemistry. 2023 Jun 20;62(12):1943-1952. doi: 10.1021/acs.biochem.2c00606. Epub 2023 Jun 4.
2
Facing Antitubercular Resistance: Identification of Potential Direct Inhibitors Targeting InhA Enzyme and Generation of 3D-pharmacophore Model by in silico Approach.面对抗结核耐药性:通过计算机模拟方法鉴定靶向InhA酶的潜在直接抑制剂并生成三维药效团模型
Adv Appl Bioinform Chem. 2023 Apr 28;16:49-59. doi: 10.2147/AABC.S394535. eCollection 2023.
3
analyses of isoniazid and streptomycin resistance-associated mutations in .
对……中异烟肼和链霉素耐药相关突变的分析
Comput Struct Biotechnol J. 2023 Feb 21;21:1874-1884. doi: 10.1016/j.csbj.2023.02.035. eCollection 2023.
4
Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line.结核分枝杆菌对一线药物耐药的分子机制的突变与见解。
Genet Mol Biol. 2023 Jan 23;46(1 Suppl 2):e20220261. doi: 10.1590/1678-4685-GMB-2022-0261. eCollection 2023.
5
Tools to Alleviate the Drug Resistance in .缓解 . 耐药性的工具
Molecules. 2022 Oct 17;27(20):6985. doi: 10.3390/molecules27206985.
6
An effective nano drug delivery and combination therapy for the treatment of Tuberculosis.一种用于治疗结核病的有效纳米药物递送和联合疗法。
Sci Rep. 2022 Jun 10;12(1):9591. doi: 10.1038/s41598-022-13682-4.
7
Aryl-n-hexanamide linked enaminones of usnic acid as promising antimicrobial agents.作为有前景的抗菌剂的扁枝衣酸芳基正己酰胺连接烯胺酮
Mol Divers. 2023 Apr;27(2):811-836. doi: 10.1007/s11030-022-10456-y. Epub 2022 May 24.
8
Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India.印度南部结核分枝杆菌异烟肼和利福平耐药的遗传决定因素的鉴定和特征分析。
Sci Rep. 2019 Jul 16;9(1):10283. doi: 10.1038/s41598-019-46756-x.
9
Biochemical and Structural Basis of Triclosan Resistance in a Novel Enoyl-Acyl Carrier Protein Reductase.新型酰基辅酶 A 还原酶中三氯生耐药的生化和结构基础。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00648-18. Print 2018 Aug.
10
Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in ?IQG-607是否是一种具有明确分子靶点的潜在金属药物或前体金属药物?
Front Microbiol. 2018 May 1;9:880. doi: 10.3389/fmicb.2018.00880. eCollection 2018.